SynBiotic SE Stock

Equities

SBX

DE000A3E5A59

Pharmaceuticals

Real-time Estimate Tradegate 03:24:50 2024-05-14 pm EDT 5-day change 1st Jan Change
8.75 EUR +5.17% Intraday chart for SynBiotic SE -9.57% +178.26%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2023 * 14.4M 15.54M Sales 2024 * 17.1M 18.45M Capitalization 38.94M 42.02M
Net income 2023 * -2M -2.16M Net income 2024 * - 0 EV / Sales 2023 * 2.74 x
Net Debt 2023 * 500K 540K Net Debt 2024 * 3.1M 3.35M EV / Sales 2024 * 2.46 x
P/E ratio 2023 *
-19.8 x
P/E ratio 2024 *
-92.4 x
Employees 104
Yield 2023 *
-
Yield 2024 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.92%
1 week-9.57%
Current month-12.42%
1 month-16.80%
3 months+8.05%
6 months+156.79%
Current year+178.26%
More quotes
1 week
8.14
Extreme 8.14
9.02
1 month
8.14
Extreme 8.14
10.40
Current year
3.13
Extreme 3.13
16.35
1 year
2.89
Extreme 2.89
16.35
3 years
2.89
Extreme 2.89
43.00
5 years
1.05
Extreme 1.05
43.00
10 years
1.05
Extreme 1.05
43.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-08-20
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
More insiders
Date Price Change Volume
24-05-12 8.32 -6.31% 35

End-of-day quote BOERSE DUESSELDORF, May 12, 2024

More quotes
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.32 EUR
Average target price
15.2 EUR
Spread / Average Target
+82.69%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW